Events2018-03-29T14:41:36+00:00

Events

“Better Science, Better Health” hosts a series of international conferences to outline research and innovation in adaptive clinical pathways and patient data usage.

Forthcoming Event

Tomorrow’s Cures: Impacts of the International Pricing Index

Hosted by GIPC and Vital Transformation

Thursday, July 18, 2019 – 4:00 – 5:00 PM Capitol Hill Visitor’s Center (Room 209-08) First St. NE, Washington, DC 20515

We invite you to join us for a discussion on how the International Pricing Index (IPI) penalizes innovation by targeting companies with the most advanced, newest products. Join GIPC and Vital Transformation to discuss the impacts of IPI on patients, outcomes, and innovation.

Recent Events

The International Pricing Index: What will be the Impact on Patients, Outcomes, and Innovation?

Wednesday, June 5, 2019
1:45 PM - 2:45 PM
BIO International Convention - Philadelphia, PA


Following Vital Transformation's research on investment success factors for biotech companies released at the European Health Forum Gastein, this session will present original research modelling the potential impact both short and long term for patients, payers, and industry for such proposals, and show how the IPI can impact access and innovation broadly. As well, our panellists will place the IPI into the context of other models currently being investigated internationally such as value based payments, managed entry agreements, and adaptive pathways.

Supporting IP in Europe


Vital Transformation leads a new consortia investigating the relationship between public funding and private investment into new innovative therapies and the supporting system of IP.

This project will develop original research investigating the success factors that create successful EU biotech companies and communicate the importance of IP in creating an ecosystem where investors are willing to lose everything 92% of the time, in order to fund the 8% of medical breakthroughs that succeed.

DIA Global 2018: Value Pricing Bootcamp: A Crash Course in How to Use Real World Evidence to Better Measure Outcomes and Evaluate New Innovative Therapies


24th June 2018, Boston, USA
Duane Schulthess, Managing Director of Vital Transformation, and Luca Pani, former Director General of the Italian Medicine's Agency and currently a Faculty Member at the University of Miami, will run a 3 hour and 15 minute Short Course outlining how best to harness RWE to better understand the price, value, and impact of next generation therapies.

Archive

Investing in EU Biotech IP – What Works?

4 December 2018 - 2.00-3.00pm CET, 8.00-9.00am ET

In this webinar we:
• Highlight the results of the research
• Expand on the datapackage used
• Discuss the gap between EU and US IP productivity in healthcare
• Address the need for IP in the global biotech sector

DIA Bioventure Day 2017 – Crown Plaza Glasgow, UK

March 28th, 2017

DIA is excited to convene its 1st BioVenture Day, in a unique format with participation of a very broad set of senior Health Care stakeholders.You will be able to explore whether the current BioVenture paradigm is delivering return for patients, investors, and the Health Care system.

EMIF: E-managing the Future of Health Data

March 16th-17th, Budapest

Harnessing electronic health records and real world evidence to create new therapies more efficiently is quickly becoming a reality. How do we maximize the benefits offered by harnessing available health data while solving issues around its reuse and work with regulators to provide the right evidence?.

Supported by:

Load More Posts